We are live on ! Find out more
ASTH icon

Astrana Health
ASTH

36 hedge funds and large institutions have $47.6M invested in Astrana Health in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 8

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

9% more capital invested

Capital invested by funds: $43.7M → $47.6M (+$3.82M)

1.29% more ownership

Funds ownership: 6.67% → 7.96% (+1.3%)

3% less funds holding

Funds holding: 37 → 36 (-1)

Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.86M
3
N
Nuveen
North Carolina
+$853K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$581K
5
CS
Credit Suisse
Switzerland
+$217K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$419K
2
Marshall Wace
Marshall Wace
United Kingdom
-$224K
3
ECM
ExodusPoint Capital Management
New York
-$208K
4
State Street
State Street
Massachusetts
-$186K
5
MF
Manchester Financial
California
-$182K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
26
Legal & General Group
United Kingdom
$28K +$9.97K +549 +49%
JP Morgan Chase
27
JP Morgan Chase
New York
$28K +$16.7K +922 +114%
UBS Group
28
UBS Group
Switzerland
$22K +$22.3K +1,227 +1,227%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$9.19K -$2.96K -163 -23%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$9K +$9.49K +523 New
MAM
31
Meeder Asset Management
Ohio
$8K +$8.39K +462 New
Morgan Stanley
32
Morgan Stanley
New York
$5K -$26K -1,433 -82%
AIP
33
Ameritas Investment Partners
Nebraska
$5K – – –
Nisa Investment Advisors
34
Nisa Investment Advisors
Missouri
$5K – – –
AG
35
Aperio Group
California
$4K +$4.63K +255 New
PCP
36
Proficio Capital Partners
Massachusetts
$1K +$1.23K +68 New
RA
37
Royce & Associates
New York
– -$419K -22,859 Closed
Marshall Wace
38
Marshall Wace
United Kingdom
– -$224K -12,201 Closed
ECM
39
ExodusPoint Capital Management
New York
– -$208K -11,352 Closed
SG Americas Securities
40
SG Americas Securities
New York
– -$106K -5,784 Closed
Canada Life
41
Canada Life
Manitoba, Canada
– -$94K -5,121 Closed
1
2

ASTH Hedge Fund Activity: Q2 2019 in Review

36 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2019, worth a combined $47.6M — up 8.7% from $43.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ASTH positions and 5 closed out — a net gain of 1 holder — while 16 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $6.57M. The largest seller was Royce & Associates, exiting entirely with an estimated $419K sold.

  • 36 institutional investors held Astrana Health (ASTH) as of Q2 2019, down from 37 in Q1 2019.
  • Funds reported $47.6M of Astrana Health stock for Q2 2019, up 8.7% quarter-over-quarter.
  • 6 funds opened new Astrana Health positions in Q2 2019 and 5 closed out, a net change of +1 holder.
  • The largest Astrana Health buyer in Q2 2019 was BlackRock, an estimated $6.57M added.
  • The largest Astrana Health seller in Q2 2019 was Royce & Associates, an estimated $419K sold.

Based on aggregated 13F filings for Q2 2019.